These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32592979)

  • 41. TMAO as a biomarker of cardiovascular events: a systematic review and meta-analysis.
    Guasti L; Galliazzo S; Molaro M; Visconti E; Pennella B; Gaudio GV; Lupi A; Grandi AM; Squizzato A
    Intern Emerg Med; 2021 Jan; 16(1):201-207. PubMed ID: 32779113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis.
    Liu Y; Dai M
    Mediators Inflamm; 2020; 2020():4634172. PubMed ID: 32148438
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid Detection of Gut Microbial Metabolite Trimethylamine N-Oxide for Chronic Kidney Disease Prevention.
    Chang YC; Chu YH; Wang CC; Wang CH; Tain YL; Yang HW
    Biosensors (Basel); 2021 Sep; 11(9):. PubMed ID: 34562929
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease.
    Gupta N; Buffa JA; Roberts AB; Sangwan N; Skye SM; Li L; Ho KJ; Varga J; DiDonato JA; Tang WHW; Hazen SL
    Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1239-1255. PubMed ID: 32212854
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microbiota-derived Trimethylamine N-oxide Predicts Cardiovascular Risk After STEMI.
    Matsuzawa Y; Nakahashi H; Konishi M; Sato R; Kawashima C; Kikuchi S; Akiyama E; Iwahashi N; Maejima N; Okada K; Ebina T; Hibi K; Kosuge M; Ishigami T; Tamura K; Kimura K
    Sci Rep; 2019 Aug; 9(1):11647. PubMed ID: 31406181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.
    Romano KA; Vivas EI; Amador-Noguez D; Rey FE
    mBio; 2015 Mar; 6(2):e02481. PubMed ID: 25784704
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trimethylamine N-oxide reduction is related to probiotic strain specificity: A systematic review.
    Cantero MA; Guedes MRA; Fernandes R; Lollo PCB
    Nutr Res; 2022 Aug; 104():29-35. PubMed ID: 35588611
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
    Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
    J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of probiotic supplementation on trimethylamine N-oxide (TMAO) in humans: A systematic review and meta-analysis of randomized controlled trials.
    Sohouli MH; Ozovanu OD; Fatahi S; Hekmatdoost A
    Clin Nutr ESPEN; 2022 Aug; 50():56-62. PubMed ID: 35871952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of trimethylamine N-oxide on inflammation and the gut microbiota in Helicobacter pylori-infected mice.
    Wu D; Cao M; Li N; Zhang A; Yu Z; Cheng J; Xie X; Wang Z; Lu S; Yan S; Zhou J; Peng J; Zhao J
    Int Immunopharmacol; 2020 Apr; 81():106026. PubMed ID: 31759863
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alzheimer's disease and gut microbiota: does trimethylamine N-oxide (TMAO) play a role?
    Arrona Cardoza P; Spillane MB; Morales Marroquin E
    Nutr Rev; 2022 Jan; 80(2):271-281. PubMed ID: 33942080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between trimethylamine N-oxide and the risk of hypertension in patients with cardiovascular disease: A meta-analysis and dose-response relationship analysis.
    Han JM; Guo L; Chen XH; Xie Q; Song XY; Ma YL
    Medicine (Baltimore); 2024 Jan; 103(1):e36784. PubMed ID: 38181288
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High salt intake increases plasma trimethylamine N-oxide (TMAO) concentration and produces gut dysbiosis in rats.
    Bielinska K; Radkowski M; Grochowska M; Perlejewski K; Huc T; Jaworska K; Motooka D; Nakamura S; Ufnal M
    Nutrition; 2018 Oct; 54():33-39. PubMed ID: 29705499
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum Trimethylamine-N-oxide Concentrations in People Living with HIV and the Effect of Probiotic Supplementation.
    Montrucchio C; De Nicolò A; D'Ettorre G; D'Ascenzo F; Lazzaro A; Tettoni M; D'Avolio A; Bonora S; Celani L; Di Perri G; Calcagno A
    Int J Antimicrob Agents; 2020 Apr; 55(4):105908. PubMed ID: 31991223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Distribution characteristics of trimethylamine N-oxide and its association with gut microbiota].
    Wang S; Xia GH; He Y; Liao SX; Yin J; Sheng HF; Zhou HW
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 36(4):455-60. PubMed ID: 27113169
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trimethylamine
    Canyelles M; Tondo M; Cedó L; Farràs M; Escolà-Gil JC; Blanco-Vaca F
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347638
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circulating gut microbiota metabolite trimethylamine N-oxide and oral contraceptive use in polycystic ovary syndrome.
    Eyupoglu ND; Caliskan Guzelce E; Acikgoz A; Uyanik E; Bjørndal B; Berge RK; Svardal A; Yildiz BO
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):810-815. PubMed ID: 31556132
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gut microbiota metabolites and risk of major adverse cardiovascular events and death: A systematic review and meta-analysis.
    Khan QA; Asad M; Ali AH; Farrukh AM; Naseem U; Semakieh B; Levin Carrion Y; Afzal M
    Medicine (Baltimore); 2024 May; 103(22):e37825. PubMed ID: 39259062
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High plasma levels of trimethylamine N-oxide are associated with poor outcome in intracerebral hemorrhage patients.
    Zhai Q; Sun T; Sun C; Yan L; Wang X; Wang Y; Sun J; Zhao Y
    Neurol Sci; 2021 Mar; 42(3):1009-1016. PubMed ID: 32705490
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?
    Canyelles M; Borràs C; Rotllan N; Tondo M; Escolà-Gil JC; Blanco-Vaca F
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.